Today: 21 May 2026
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts
5 November 2025
3 mins read

Tesla Stock Today (Nov. 5, 2025): TSLA Climbs Ahead of High‑Stakes Musk Pay Vote as Europe Sales Slide

Dateline: Nov. 5, 2025 — Tesla (NASDAQ: TSLA) shares advanced Wednesday as investors braced for a pivotal shareholder vote on CEO Elon Musk’s proposed pay package, even as fresh data showed sharp October sales declines in key European markets and a new lawsuit hit Tesla’s insurance arm.

Market snapshot (intraday)

  • Price: ~$465 (up ~4% intraday)
  • Day’s range: $440.86–$465.10
  • 52‑week range: $214.25–$488.54
  • Market cap (approx.): $1.48T
    Figures above reflect Nov. 5, 2025, intraday data. (Source for range/market data: LSEG/Reuters company page for TSLA.)

What’s moving TSLA today

1) The Musk pay vote—“pay him or risk losing him,” board warns

Tesla’s board is urging investors to approve a pay package for Musk valued up to $878 billion over the next decade, arguing that only he can deliver Tesla’s ambitions in AI, robotaxis, and robotics. The board has framed the decision starkly: reward Musk or risk his departure—an outcome they say could damage Tesla’s valuation. A vote is scheduled Thursday, Nov. 6.

Counter‑pressure intensified this week. Norway’s $2.1 trillion wealth fund—one of Tesla’s largest outside shareholders—said it will vote against the package, aligning with proxy advisers ISS and Glass Lewis over concerns about size, dilution and “key person risk.” Still, the proposal could pass given Tesla’s retail shareholder base and Texas’ rules allowing Musk to vote his own stake. Reuters

Why this matters for the stock: The pay plan is effectively a referendum on Tesla’s AI‑led strategy and Musk’s centrality to it. A “yes” could cement the narrative of Musk steering the next leg of growth; a “no” risks headline volatility and questions about leadership continuity. Reuters+1

2) European sales swoon adds fundamental headwinds

New registration data show Tesla’s Germany sales more than halved in October (‑53.5% y/y to 750 units) even as overall BEV sales in the country jumped nearly 48%. In the U.K., Tesla registrations fell 51% to 495 vehicles. The declines extend a recent pattern of softness across parts of Europe amid aging models and intensifying competition.

In China, October sales of China‑made Teslas fell 9.9% year over year, according to data published Tuesday—another sign of uneven demand into year‑end.

3) Fresh legal risk: lawsuit targets Tesla insurance unit

Separately, Tesla General Insurance was sued in Arizona federal court, accused of systematically underpaying claims tied to uninsured/underinsured motorist coverage. The proposed class action could broaden to other states, according to plaintiffs’ counsel. Tesla did not immediately comment. Legal noise rarely drives long‑term valuation on its own, but it adds to today’s risk mix.


What today’s setup means for investors

Tug‑of‑war between narrative and numbers:

  • Narrative tailwind: The board’s messaging and retail support raise odds the pay package passes, reinforcing the AI/robotaxi storyline that underpins Tesla’s premium multiple.
  • Fundamental friction: Europe and China prints point to near‑term demand challenges and a tougher competitive field—factors that can cap multiple expansion if they persist.

Key levels to watch: With shares trading in the mid‑$460s, TSLA sits within reach of its 52‑week high near $489, a zone traders often watch for potential resistance. A decisive break above could embolden momentum buyers; failure there could keep the stock range‑bound into the vote results. (52‑week data from LSEG/Reuters.)


The latest, at a glance

  • TSLA up ~4% intraday ahead of the shareholder meeting.
  • Board escalates rhetoric: approve up to $878B in stock awards or risk Musk’s exit.
  • Norway’s wealth fund votes “no”; proposal could still pass given voting dynamics. Reuters
  • Germany/U.K. October sales halved; China‑made sales ‑9.9% y/y.
  • New lawsuit hits Tesla’s insurance arm.

What to watch next (Nov. 6 and beyond)

  1. Vote results and commentary from Tesla’s annual meeting on Thursday, Nov. 6—including any fresh guidance around robotaxis, FSD progress and humanoid robotics initiatives.
  2. Regional demand updates: follow‑on data from Europe and China to see whether October’s weakness persists into Q4.
  3. Legal and regulatory headlines tied to Autopilot/FSD and insurance operations, which can stoke volatility.

Editorial note for Google News & Discover

This article synthesizes intraday market data and news published on Nov. 5, 2025 (and immediate prior day for context) from reputable outlets including Reuters/LSEG and associated regulatory and court filings where cited. Figures are intraday and subject to change after the close.

This content is for informational purposes only and is not investment advice.

Stock Market Today

  • Thales (ENXTPA:HO) Shares Decline but DCF Model Indicates Undervaluation
    May 21, 2026, 1:56 AM EDT. Shares of Thales (ENXTPA:HO) have fallen 12.8% over the past month and are down 9.7% year on year, despite strong long-term returns of 79.2% and 203.0% over three and five years respectively. Recent sector-specific developments in aerospace and defense, alongside broader market sentiment, contribute to price volatility. A discounted cash flow (DCF) analysis estimates Thales's intrinsic value at around €306.76 per share, suggesting the current price of €229.50 trades at a 25.2% discount and that the stock is undervalued. The P/E ratio remains a key metric but further valuation aspects need evaluation, as Thales scores 4 out of 6 on Simply Wall St's valuation checks. Investors should consider these factors when assessing the stock's potential.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Nuvve Holding Corp’s Stock Skyrockets 50% – Can This EV Grid Pioneer Overcome the Odds?
Previous Story

Nuvve Holding Corp’s Stock Skyrockets 50% – Can This EV Grid Pioneer Overcome the Odds?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?
Next Story

IonQ Q3 2025 Earnings (Nov. 5): Revenue Soars 222% to $39.9M, Full‑Year Outlook Raised; Here’s What It Means for IONQ Stock

Go toTop